A Highly Immunogenic Vaccine Platform Against Encapsulated Pathogens Using Chimeric Probiotic Escherichia coli Membrane Vesicles

The authors constructed a probiotic E. coli clone harboring the genetic locus responsible for biogenesis of serotype 14 pneumococcal capsular polysaccharides as a model antigen.